Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) Accounts Payables (2022 - 2026)

Updated

Impact Biomedical (IBO) recorded Accounts Payables of $467,000 in Q2 2026, down 15.7% from $554,000 a year earlier but up 24.9% from the prior quarter.

Analysis

Impact Biomedical (IBO) Accounts Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, Impact Biomedical reported Accounts Payables of $347,000, down 51.3% from FY2024.

  • Annual Accounts Payables has a three-year compound annual growth rate of -13.7% (FY2022 to FY2025).
  • Across earlier years, Accounts Payables came in at $713,000 in FY2024 (-14.3%), $832,000 in FY2023 (+54.4%) and $539,000 in FY2022.
  • Quarterly Accounts Payables has ranged from $301,000 in Q2 2023 to $1.02 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Accounts Payables has declined for seven consecutive quarters, with an average decline of 17.0% over the last eight quarters.
  • Peak year-over-year performance for Accounts Payables in the last five years was growth of 227.6% in Q2 2024, against a decline of 51.3% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $374,000 (Q1 2026), $347,000 (Q4 2025) and $576,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 467,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 467,000.00
Mar 31, 2026 374,000.00
Dec 31, 2025 347,000.00
Sep 30, 2025 576,000.00
Jun 30, 2025 554,000.00
Mar 31, 2025 615,000.00
Dec 31, 2024 713,000.00
Sep 30, 2024 1.00 Mn
Jun 30, 2024 986,000.00
Mar 31, 2024 1.02 Mn
Dec 31, 2023 832,000.00
Sep 30, 2023 476,000.00
Jun 30, 2023 301,000.00
Dec 31, 2022 539,000.00
API Access

Impact Biomedical Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=IBO&period=max&api_key=YOUR_API_KEY